loading
前日終値:
$1.45
開ける:
$1.55
24時間の取引高:
20.19M
Relative Volume:
1.40
時価総額:
$105.49M
収益:
$1.20M
当期純損益:
$-52.41M
株価収益率:
-2.5385
EPS:
-0.91
ネットキャッシュフロー:
$-31.25M
1週間 パフォーマンス:
+23.08%
1か月 パフォーマンス:
+348.18%
6か月 パフォーマンス:
+101.80%
1年 パフォーマンス:
-2.18%
1日の値動き範囲:
Value
$1.535
$2.30
1週間の範囲:
Value
$1.42
$2.30
52週間の値動き範囲:
Value
$0.387
$3.87

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
名前
Rani Therapeutics Holdings Inc
Name
セクター
Healthcare (1144)
Name
電話
(408) 457-3700
Name
住所
2051 RINGWOOD AVENUE, SAN JOSE
Name
職員
106
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
RANI's Discussions on Twitter

RANI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RANI
Rani Therapeutics Holdings Inc
2.2399 141.43M 1.20M -52.41M -31.25M -0.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.74 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
649.74 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.60 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
806.26 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
187.71 41.29B 398.11M -1.03B -868.57M -5.7032

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-02 開始されました Oppenheimer Outperform
2024-06-14 開始されました Maxim Group Buy
2024-06-13 開始されました Rodman & Renshaw Buy
2023-04-17 再開されました BTIG Research Buy
2022-10-11 開始されました UBS Buy
2022-07-27 開始されました H.C. Wainwright Buy
2022-06-13 開始されました Wedbush Outperform
すべてを表示

Rani Therapeutics Holdings Inc (RANI) 最新ニュース

pulisher
05:37 AM

Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com

05:37 AM
pulisher
04:58 AM

Multi asset correlation models including Rani Therapeutics Holdings Inc.2025 Stock Rankings & Low Drawdown Momentum Ideas - newser.com

04:58 AM
pulisher
04:40 AM

Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com

04:40 AM
pulisher
04:38 AM

Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthIPO Watch & Safe Capital Preservation Plans - newser.com

04:38 AM
pulisher
01:41 AM

Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025Short Setup & Real-Time Volume Analysis Alerts - newser.com

01:41 AM
pulisher
01:15 AM

Institutional scanner results for Rani Therapeutics Holdings Inc.July 2025 Setups & Verified Momentum Stock Watchlist - newser.com

01:15 AM
pulisher
Oct 30, 2025

Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Rani (Nasdaq: RANI) to present RT-116 bioequivalence data in dogs at ObesityWeek 2025 - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Short interest data insights for Rani Therapeutics Holdings Inc.Stop Loss & Intraday High Probability Setup Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Can momentum traders help lift Rani Therapeutics Holdings Inc.Earnings Performance Report & Weekly Sector Rotation Insights - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineOptions Play & AI Powered Market Entry Strategies - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Rani Therapeutics (NASDAQ:RANI) Director Mir Imran Buys 2,083,334 Shares - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Rani Therapeutics Hits New 52-Week High of $3.87, Marking Major Milestone - Markets Mojo

Oct 28, 2025
pulisher
Oct 28, 2025

Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, Israel Englander, Ken Griffin, Michael Burry, Warren Buffett, ExodusPoint Capital, Rani Therapeutics Holdings Inc (RANI), Coca-Cola Co (KO), and More - Insider Monkey

Oct 28, 2025
pulisher
Oct 28, 2025

Rani Therapeutics Holdings Insider Bought Shares Worth $1,260,417, According to a Recent SEC Filing - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Will Rani Therapeutics Holdings Inc. bounce back from current supportMarket Activity Report & Weekly Breakout Stock Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis tools2025 Macro Impact & Daily Volume Surge Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics director Imran Mir a buys $1.26 million in stock - Investing.com Philippines

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics director Imran Mir a buys $1.26 million in stock By Investing.com - Investing.com South Africa

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114 - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics appoints new directors and closes private placement By Investing.com - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics appoints new directors and closes private placement - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

Rani Therapeutics Announces Board Changes - TradingView

Oct 27, 2025

Rani Therapeutics Holdings Inc (RANI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rani Therapeutics Holdings Inc (RANI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
South Cone Investments Limited
10% Owner
Oct 21 '25
Sale
2.77
4,000,000
11,074,000
2,379,194
South Cone Investments Limited
10% Owner
Oct 20 '25
Sale
2.41
1,923,000
4,637,314
6,379,194
McKinley Kate
Chief Business Officer
Dec 13 '24
Buy
1.67
17,960
29,993
17,960
Imran Talat
Chief Executive Officer
Dec 09 '24
Buy
1.94
10,296
19,974
494,751
$37.28
price up icon 1.00%
$93.15
price up icon 0.57%
$28.41
price down icon 0.94%
$103.17
price down icon 1.37%
biotechnology ONC
$309.55
price up icon 0.54%
$187.76
price down icon 3.41%
大文字化:     |  ボリューム (24 時間):